# Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

> **NCT06386497** · NA · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 15 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** Nocturnal translational vestibular stimulation

## Key facts

- **NCT ID:** NCT06386497
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-11
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386497, "Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06386497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*